Gurmeet Singh, MD
Cardiovascular Disease · Dover, DENPI 1417927732
Payments from drug & device makers
Across 522 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Pfizer$1K
- Johnson & Johnson$786
- Medtronic$607
- AstraZeneca$579
- E.r. Squibb & Sons, L.L.C.$569
- plus $4K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 87 | $1,299 |
| Pfizer | 72 | $1,037 |
| Johnson & Johnson | 49 | $786 |
| Medtronic(2 entities) | 11 | $607 |
| AstraZeneca | 33 | $579 |
| E.r. Squibb & Sons, L.L.C. | 40 | $569 |
| Amgen | 35 | $561 |
| Boehringer Ingelheim | 28 | $532 |
| Merck | 25 | $416 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 24 | $380 |
| Esperion Therapeutics, Inc. | 29 | $350 |
| Abiomed | 8 | $347 |
| Novo Nordisk | 15 | $277 |
| Bayer | 15 | $270 |
| Akcea Therapeutics, Inc. | 4 | $202 |
| Abbott | 10 | $174 |
| Boston Scientific | 2 | $156 |
| Amarin Pharma, Inc. | 6 | $85 |
| Canon Medical Systems USA, Inc. | 1 | $52 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| Cook Medical LLC | 1 | $45 |
| Agepha Pharma FZ LLC | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Edwards Lifesciences | 2 | $40 |
| Heartflow, Inc. | 2 | $36 |
| Kestra Medical Technology Services, Inc. | 2 | $34 |
| Bridgebio Pharma, Inc. | 2 | $30 |
| Bardy Diagnostics, Inc. | 2 | $26 |
| Siemens Medical Solutions USA, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Sanofi | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $18 |
| Biotronik Inc. | 1 | $18 |
| Cardiva Medical, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $16 |
| Covidien LP | 1 | $14 |
| Daxor Corporation | 1 | $11 |
How this compares
$9,208 in reported general payments places this provider in the 70th percentile of 104 cardiovascular disease providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Dover
- Eranga HaththotuwaDover$15K
- Michael SheaDover$6K
- John ShuckDover$3K
- Khaled EljazzarDover$3K
- Jennifer EakinDover$2K
- Anthony ClayNewark$2.3M
- William WeintraubNewark$1.3M
- Vinay HosmaneWilmington$256K
- Wasif QureshiBear$133K
- Sourin BanerjiNewark$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.